CANTOR FITZGERALD, L. P. - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 63 filers reported holding AMRYT PHARMA PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
CANTOR FITZGERALD, L. P. ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$1,195,064
+199743.5%
81,9660.0%0.02%
+92.3%
Q4 2022$598
-99.9%
81,9660.0%0.01%
+8.3%
Q3 2022$567,000
-1.0%
81,966
-0.0%
0.01%
+9.1%
Q2 2022$573,000
-32.0%
81,985
-19.6%
0.01%
-82.8%
Q1 2022$843,000
-2.4%
101,985
+27.5%
0.06%
+3.2%
Q4 2021$864,00079,9660.06%
Other shareholders
AMRYT PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,912,00026.04%
Stonepine Capital Management, LLC 6,298,348$44,025,00020.48%
MPM ASSET MANAGEMENT LLC 2,668,843$18,655,0007.87%
Aquilo Capital Management, LLC 1,866,652$13,048,0004.45%
New Leaf Venture Partners, L.L.C. 449,737$3,144,0002.04%
Global Frontier Investments LLC 435,000$3,040,0001.42%
Rubric Capital Management LP 3,600,000$25,164,0001.32%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$44,272,0001.01%
Telemetry Investments, L.L.C. 121,670$850,0001.01%
Clearline Capital LP 631,942$4,417,0000.57%
View complete list of AMRYT PHARMA PLC shareholders